PD Dr. Michael Erdmann

Department of Dermatology

Model soups improve performance of dermoscopic skin cancer classifiers (2022) Maron RC, Hekler A, Haggenmüller S, von Kalle C, Utikal JS, Müller V, Gaiser M, et al. Journal article S1-guideline atypical fibroxanthoma (AFX) and pleomorphic dermal sarcoma (PDS) (2022) Helbig D, Ziemer M, Dippel E, Erdmann M, Hillen U, Leiter U, Mentzel T, et al. Journal article Das maligne Melanom im Kindesalter (2022) Schellerer V, Besendorfer M, Erdmann M Journal article c-Kit inhibitors for unresectable or metastatic mucosal, acral or chronically sun-damaged melanoma: a systematic review and one-arm meta-analysis (2021) Steeb T, Wessely A, Petzold A, Kohl C, Erdmann M, Berking C, Heppt M Journal article, Review article Rasches Ansprechen eines multilokulär metastasierten Merkelzellkarzinoms bei unklarem Primarius auf Avelumab (2021) Bender-Säbelkampf S, Berking C, Erdmann M Conference contribution, Abstract of a poster Melanoma in Pregnancy: CLAUDIUS - a retrospective, multicenter Study to evaluate the Risk of transplacental Transmission to the unborn Child (2021) Gaiser MR, Mueller V, Erdmann M, Buehler B, Dugas-Breit S, Schatton K, Reinhardt L, et al. Conference contribution Clinical Prognostic Factors in metastatic Choroidal Melanoma (2021) Koch E, Petzold A, Wessely A, Dippel E, Erdmann M, Heinzerling L, Hohberger B, et al. Conference contribution Serositis in Association with System Therapy with Checkpoint Inhibitors - More frequent than thought? - An Evaluation of the SERIO Adverse Event Registry (2021) Zierold S, Kramer R, Erdmann M, Akcetin SL, Maier AM, Koenig A, Theurich S, et al. Conference contribution Rapid Response of locally distinct CD30 positive primary cutaneous anaplastic large T-Cell Lymphoma under Brentuximab Vedotin (2021) Bender-Säbelkampf S, Berking C, Erdmann M Conference contribution Does In-transit-Metastasis in lower Extremity Melanoma Patients correlate with anatomical Lymphatic Drainage Pathways? (2021) Müller K, Schellerer V, Berking C, Erdmann M Conference contribution